2019 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ghmm who wrote (116)	2/16/2019 4:36:39 PM
From: BulbaMan	of 280

Yeah, yours is the sole portfolio holding AXON. The 2/14/19 PR was a bit confusing but the 2/7/19 PR seems to indicate that shareholders of AXON now have the same number of shares in AXGT, which will be traded. Here’s the relevant bullet point from the 2/7/19 PR: “Axovant Sciences Ltd. intends to change its name to Axovant Gene Therapies Ltd. and ticker symbol to “AXGT” to reflect its exclusive focus on gene therapies” finance.yahoo.com So my inclination is to just substitute AXGT for AXON in your portfolio. But I’m open to change if you or anyone else (e.g., a real world holder of AXON) has better information. Peace & good health, Bulba

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next